Regulation 54

preserves the biological and functional properties of the reproductive cell or embryo; and

minimises the risk of contamination of the reproductive cell or embryo.

ensure that the reproductive cell or embryo is at all times during the transfer packaged and transported in a validated device that is appropriate for the reproductive cell or embryo and the intended use of the reproductive cell or embryo;

implement and maintain a system to prevent or control the spread of any communicable disease due to the contamination or infection of any reproductive cell or embryo in the licensee’s custody, including the traceability of all equipment and materials used in the processing of the reproductive cell or embryo;

ensure that the reproductive cell or embryo is transported and transferred in appropriate environmental conditions;

ensure that an instruction sheet accompanies each transfer from the licensee of any reproductive cell or embryo stating all of the following information:

the results of all tests performed on the person from whom the reproductive cell is collected or from whose reproductive cell the embryo is created;

the appropriate storage condition for the reproductive cell or embryo prior to its clinical use;

any special requirement or measure that the medical practitioner using the reproductive cell or embryo must take to ensure the safe and effective use of the reproductive cell or embryo;

the measures that must be taken if there is any evidence of damage to or mislabelling of the reproductive cell or embryo or its packaging; and

in relation to each transfer from the licensee of any reproductive cell or embryo, ensure that the movement of the reproductive cell or embryo is tracked in a document, and that every person who receives the reproductive cell or embryo signs the document upon receipt.